Nanomedicines for breast cancer theranostics /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Thorat, Nanasaheb D., Bauer, Joanna
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam : Elsevier, 2020.
Colección:Micro and nano technologies series
Temas:
Breast > Cancer > Chemotherapy.
Nanomedicine.
Breast Neoplasms
Neoplasms > drug therapy
Nanomedicine
Sein > Cancer > Chimioth�erapie.
Nanom�edecine.
Breast > Cancer > Chemotherapy
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Front Cover
  • Nanomedicines for Breast Cancer Theranostics
  • Nanomedicines for Breast Cancer Theranostics
  • Copyright
  • Contents
  • Contributors
  • Biography
  • Preface
  • Acknowledgment
  • 1
  • Nanomedicine
  • 1
  • Nanomedicine: next generation modality of breast cancer therapeutics
  • 1.1 Introduction
  • 1.1.1 Breast cancer
  • 1.1.2 Breast cancer grading
  • 1.1.3 Conventional breast cancer therapies
  • 1.2 Cancer nanomedicine
  • Acknowledgments
  • References
  • 2
  • Physical and chemical properties of nanomaterials
  • 2.1 Introduction
  • 2.2 Physical properties
  • 2.2.1 Melting point
  • 2.2.2 Mechanical properties
  • 2.2.2.1 Hardness, plasticity, and Young's modulus/strength
  • 2.2.3 Optical properties
  • 2.2.4 Magnetic properties
  • 2.2.4.1 Superparamagnetic behavior
  • 2.2.4.2 Giant magnetoresistance (GMR)
  • 2.2.4.3 Tunneling magnetoresistance (TMR)
  • 2.3 Chemical properties
  • 2.3.1 Surface energy
  • 2.3.2 Chemical potential
  • 2.3.3 Oxidation process at nanoscale
  • 2.3.4 Catalysis
  • 2.3.5 Functionalization of nanostructures
  • 2.3.5.1 Surface functionalization
  • 2.3.5.2 End wall functionalization
  • 2.3.5.3 Inner wall functionalization
  • References
  • 3
  • Biological prospectives of hybrid nanostructures
  • 3.1 Introduction
  • 3.2 Hybrid nanostructures
  • 3.3 Breast cancer
  • 3.4 Current trends and challenges in treatments of breast cancer
  • 3.5 Hybrid nanostructures in breast cancer nanotheranostics
  • 3.5.1 Liposomal hybrid nanoparticles
  • 3.5.2 Micelles hybrid nanostructures
  • 3.5.3 Porous silica-based hybrid nanoparticles
  • 3.5.4 Polymeric hybrid nanoparticles
  • 3.5.5 Gold-based hybrid nanoparticles
  • 3.5.6 Nanotube-based hybrid nanoparticles
  • 3.6 Conclusion and future perspectives
  • References
  • 4
  • Novel hybrid nanostructure for breast cancer application
  • 4.1 Introduction
  • 4.2 Hybrid nanostructures in breast cancer applications
  • 4.2.1 Liposomal hybrid nanostructures
  • 4.2.2 Silica based hybrid nanostructures
  • 4.2.3 Hybrid magnetic nanostructures
  • 4.2.4 Gold based hybrid nanostructures
  • 4.2.5 Carbon-based hybrid nanostructures
  • 4.3 Conclusion
  • References
  • 2
  • Theranostics
  • 5
  • Synergy between nanoparticles and breast cancer theranostics
  • 5.1 Introduction
  • 5.2 Nanoparticles for synergistic breast cancer diagnostics
  • 5.2.1 Monomodal diagnostics
  • 5.2.1.1 Fluorescence imaging (FI)
  • 5.2.1.1.1 MCh-QDs
  • 5.2.1.1.2 CQDs
  • 5.2.1.1.3 SPDs
  • 5.2.1.2 Computed tomography (CT)
  • 5.2.1.3 Magnetic resonance imaging (MRI)
  • 5.2.2 Bimodal diagnostics
  • 5.2.2.1 FI and CT
  • 5.2.2.2 FI and MRI
  • 5.2.2.3 CT and MRI
  • 5.2.3 Trimodal diagnostics
  • 5.3 Nanoparticles for synergistic breast cancer therapeutics
  • 5.3.1 Monomodal therapeutics
  • 5.3.1.1 Chemotherapy (CHT)
  • 5.3.1.2 Magnetic hyperthermia therapy (MHT)
  • 5.3.1.3 Photodynamic/photothermal therapy (PDT/PTT)
  • 5.3.2 Bimodal therapeutics
  • 5.3.2.1 CHT and MHT
  • 5.3.2.2 CHT and PDT/PTT

Ejemplares similares